Cytokinetics Inc (CYTK)

R&D Expense Growth

19.59%

Fiscal year · Period ending:

CYTK logo

CYTK R&D Expense Growth

Latest reported19.59%
CYTK FY R&D Growth (YoY) (0.00% → 19.59%)
High-resolution chart · PNG

CYTK r&d expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Cytokinetics Inc R&D Expense Growth — Annual fiscal periods
Period endingR&D Expense Growth
19.5909%
2.8126%
37.0869%
50.5665%
64.9679%
12.5701%
-3.3769%
-1.2858%
50.7521%
29.0939%
4.4388%
-10.1598%
38.7369%
-4.1391%
-2.1861%
-4.5858%
-26.1538%
1.0527%
8.4571%
21.3335%
1.7174%
17.295%
19.6313%
35.6042%
101.49%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.